Isu Abxis, Active Community... Stock Price Up 0.5%.

At this time, posts about Isu Abxis are rapidly increasing on portals and securities communities. Today, foreigners have tentatively net purchased 57,930 shares of Isu Abxis, while institutions have net sold 3,000 shares. Isu Abxis, an affiliate of the Isu Group, is known as a company that develops antibiotic treatments and provides medical services.

As of 1:30 PM on the 10th, the stock price of Isu Abxis is 10,050 KRW, up 0.5% from the previous day, with a trading volume of 2,638,564 shares, which is about 29.1% of the 5-day average trading volume. On March 5th, Isu Abxis became a market issue with the news "Gaucher disease treatment Abcertin completes Phase 1 clinical trial... stock price rises."

In addition to Isu Abxis, posts by investors are also rapidly increasing for Gamevil (063080), Samjin L&D (054090), and Guyeong Tech (053270).

※Source: AI Investment Assistant AI Rassi

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.